Bacterin International, Inc. Announces Preliminary First Quarter 2014 Revenue

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, announced today preliminary unaudited revenue for the first quarter of 2014.

The Company is expecting total net revenue for the first quarter of 2014 to be in the range of $8.7 million to $8.9 million, representing a sequential increase of approximately 7% over the fourth quarter of 2013, and an increase of 2% when compared to $8.6 million reported for the first quarter of 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news